β-Cell Centric Classification of Diabetes:

Slides:



Advertisements
Similar presentations
What Causes Microvascular and Macrovascular Complications in Patients with Type 2 Diabetes? Charles A. Reasner, MD Professor of Medicine University of.
Advertisements

Clinical Presentation of Type 2 Diabetes 1. Risk Factors for Prediabetes and Type 2 Diabetes Family history of diabetes mellitus Cardiovascular disease.
DM Dewasa EVA DECROLI. Problems Increased of prevalence Cronic complications ex. Diabetic Foot Problems Prevention, primer, secunder tertier.
Gastric Surgery for Severe Obesity David L. Gee, PhD Professor of Food Science and Nutrition Central Washington University.
inse.ppt1 Glucose homeostasis Insulin lowers blood glucose (yes, but...) Insulin enables glucose metabolism in cells (yes, but...) Insulin exerts.
Goals: 1) Understand the mechanism for ↑LDL in Type II diabetes 2) Having previously established the link between endothelial cell damage (loss of inhibitory.
Therapy of Type 2 Diabetes Mellitus: UPDATE
Adult Medical-Surgical Nursing
Unit 5 – Public Health Chronic Diseases
Diabetes
Therapy of Type 2 Diabetes Mellitus: UPDATE Glycemic Goals in the Care of Patients with Type 2 Diabetes ADA and AACE Guidelines: Room For Improvement.
Diabetes Mellitus 101 for Medical Professionals An Aggressive Pathophysiologic Approach to Cardiometabolic Therapy for Type 2 Diabetes: Stanley Schwartz.
IR and Hyperinsulinemia Insulin Resistance: A Survival Mechanism, Gone Awry Stan Schwartz MD,FACP Affiliate, Main Line Health System Emeritus, Clinical.
COST-EFFECTIVENESS OF BARIATRIC SURGERY IN SEVERELY OBESE PATIENTS WITH DIABETES Department of Surgery Journal Club for March 7, 2013.
The Obesity/Diabetes Epidemic: Perspectives, Consequences, Prevention, Treatment Stan Schwartz MD, FACP, FACE Private Practice, Ardmore Obesity Program.
Diagnosing Diabetes In Adults– Type 1, LADA, or Type 2? Stanley Schwartz MD, FACE, FACP Affiliate Main Line Health Emeritus, Clinical Assoc. Prof. of Medicine.
The Obesity/Diabetes Epidemic: Adiposopathy & Obesity- The New Disease! Dx & (Rx) of Insulin Resistance & early DM Part 4 Stan Schwartz MD, FACP, FACE.
IR and Hyperinsulinemia Insulin Resistance: A Survival Mechanism, Gone Awry Stan Schwartz MD,FACP Affiliate, Main Line Health System Emeritus, Clinical.
IR and Hyperinsulinemia Insulin Resistance: A Survival Mechanism, Gone Awry Stan Schwartz MD,FACP Affiliate, Main Line Health System Emeritus, Clinical.
Diagnosing Diabetes In Adults– Type 1, LADA, or Type 2? Stanley Schwartz MD, FACE, FACP Affiliate Main Line Health Emeritus, Clinical Assoc. Prof. of Medicine.
IR and Hyperinsulinemia Insulin Resistance: A Survival Mechanism, Gone Awry Stan Schwartz MD,FACP Affiliate, Main Line Health System Emeritus, Clinical.
Diabetes Mellitus 101 for Medical Professionals An Aggressive Pathophysiologic Approach to Cardiometabolic Therapy for Type 2 Diabetes: Stanley Schwartz,
Insulin Resistance Progression to Diabetes. Hypertension: BP >140/90 Dyslipidemia: ◦TG >150 mg/dL (1.7 mmol.L) ◦HDL-C
The Obesity/Diabetes Epidemic: Adiposopathy & Obesity- The New Disease! Dx & (Rx) of Insulin Resistance & Early DM Part 5 Stan Schwartz MD, FACP, FACE.
Successful use of Nutritional Guidelines to Prevent Type II Diabetes James J. Kenney PhD, RD.
Part 4.
Diabetes Mellitus 101 for Cardiologists (and Alike): 2015 Stan Schwartz MD,FACP Affiliate, Main Line Health System Emeritus, Clinical Associate Professor.
Natural History of Type 2 Diabetes Adapted from International Diabetes Center (IDC), Minneapolis, Minnesota. ObesityIFG*DiabetesUncontrolled Hyperglycemia.
Diabetes Mellitus 101 for Cardiologists (and Alike): 2015 Stan Schwartz MD,FACP Affiliate, Main Line Health System Emeritus, Clinical Associate Professor.
Diabetes Mellitus 101 for Cardiologists (and Alike): 2015
The Obesity/Diabetes Epidemic: Adiposopathy & ‘Obesity’- The New Disease! Weight Management in Obesity and DM: Emphasis on New Medical Therapies Stan Schwartz.
IR and Hyperinsulinemia Insulin Resistance: A Survival Mechanism, Gone Awry Stan Schwartz MD,FACP Affiliate, Main Line Health System Emeritus, Clinical.
Practical Implementation as a Discussion with the Patient Practical Use of SGLT-2 Inhibitors in T2DM: Clinical Pearls- Perlas de Sabiduria Stan Schwartz.
Diabetes Mellitus 101 for Cardiologists (and Alike): 2015 Stan Schwartz MD,FACP Affiliate, Main Line Health System Emeritus, Clinical Associate Professor.
Diabetes. Warm Up Questions How many people do you know have diabetes? What is diabetes? Diabetes can be dangerous if it’s not treated. What happens if.
Current Classification of DM Update on Diabetes Classification Celeste C. Thomas, MD, MSa,*, Louis H. Philipson, MD, PhD,Med Clin N Am 99 (2015) 1–16.
Acute Infections and Insulin Requirements In pre-diabetic individuals acute infections may induce a temporary state of diabetes requiring short-term insulin.
Preventive Measures Infection & Delayed Wound Healing Frequent dental visits to assess plaque control Risk assessment profiles to identify risk factors.
A Process Of Precision Medicine- Matching Right Drug to Right Patient.
What Is the Disease of Obesity?
Efficacy of Immunotherapy in T1DM: Some Can Delay Decline in C-peptide
CV Risk of SU and Insulin
Control of Blood Sugar Diabetes Mellitus.
Avoid Early Insulin Therapy (except in Ketosis-prone) Vicious Circle(s) of Hyperinsulinemia- Result in Weight Gain and Hypoglycemia Blood glucose rises.
The β-Cell Centric Classification of DM
Hippocrates Prize Prof A. Kokkinos (Greece).
Once Upon a Time, Insulin Resistance was Adaptive… but Not Today
A Process Of Precision Medicine- Matching Right Drug to Right Patient
DIABETES MELLITUS DR HEYAM AWAD FRCPATH.
WHAT ABOUT COMPLICATIONS OF DIABETES?
Beta-Cell Classification of Diabetes and the Egregious Eleven: Logic for Newer Algorithms/ Processes of Care The Role of Newer Anti-Diabetes Medications.
Most Mechanisms of B-Cell Damage (Hyperglycemia) Overlap with Causes of Vascular Disease : Provides Logic for Treatment Regimes and CV Benefits.
Natural History of ALL DM
In T2DM, β-Cell Mass in Islets is Significantly Reduced
A Clinical-Translator’s Point-of-View:
Unified Theory of Diabetes and All Its Complications
Part 5 Stan Schwartz MD, FACP, FACE Private Practice, Ardmore
Treatment of Type 2 Diabetes: Pathophysiology Conclude: do so without Hypoglycemia or Visceral Fat Weight Gain 1.
Pushback What about ‘pure’ Insulin Resistance Syndromes?
Metabolic Changes in Diabetes Mellitus
Effect of Metabolic Surgery on diabetes and hypertension
Diabetes Mellitus.
by:Graham Holmes, Jacob Peters, and Kassie Shepherd
Macrovascular Complications Microvascular Complications
Natural History of ALL DM
Value of construct 1. Fits with Harry Keen’s construct
The β-Cell Centric Classification of DM
WHAT ABOUT COMPLICATIONS OF DIABETES?
eCB pathways involved in obesity-/HFD-associated CKD
Once Upon a Time, Insulin Resistance was Adaptive… but Not Today
Presentation transcript:

β-Cell Centric Classification of Diabetes: Implications for Classification, Diagnosis, Prevention, Therapy, Research INSULIN** RESISTANCE Environment* G E N E Epigenetics Inflammation/ Immune Regulation Polygenic Monogenic β-Cell secretion/mass FINAL COMMON DENOMINATOR *Environment=Genetic suceptibility to eg: viruses, endocrine disruptors, food AGEs, Gut Biome **Insulin Resistance= Centrally Induced, Peripheral, Stress Hormones, Gut Biome

Primary Hyperinsulinemia- Genetic propensity( Corkey) INACTIVITY,DIET FFAs INFLAMMATION, OXIDATIVE STRESS INCREASED PAI-1,NFKB,MMPS, ROS,AP-1,Egr-1

Hyperinsulinemia Early in Natural History of DM: ie: May Cause Diabetes by Causing Insulin Resistance in PI3 Kinase Pathway But reduced insulin right after bariatric op- results in Fast improvement in resolution of diabetic state (PI-3 Kinase pathway, before IR improved Pories WJ, MacDonald KG Jr, Morgan EJ, et al. Surgical treatment of obesity and its effect on diabetes: 10-y followup. Am J Clin Nutr 1992;55(2 Suppl):582S-5S. Jimenez A, Perea V, Corcelles R, Moize V, Lacy A, Vidal J. Metabolic effects of bariatric surgery in insulin-sensitive morbidly obese subjects. Obes Surg 2013;23:494-500.

Potential Causes of Insulin Resistance and Their Interplay Central IR Loss of dopamine surge in SCN increased appetite Increased sympathetic tone Hyperinsulinemia Biome IR Peripheral IR Inflammation IR

Natural History of ALL DM Age 0-15 15-40+ 15-50+ 25-70+ Macrovascular Complications Disability IR Phenotype MI CVA Amp IGT ALL DM DEATH Blindness Amputation CRF ETOH BP Smoking Eye Nerve Kidney Disability Microvascular Complications Risk of Dev. Complications 5

Genes, Inflam Envir Hyperinsulinemia FINAL COMMON DENOMINATOR

ARE THE SAME AS THOSE THAT DAMAGE THE Beta-Cell * * * *